| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1993 Oxford University Press
RESEARCH-ARTICLE |
Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome)
Institut fur Humangenetik, Mediznische Universität, Ratzeburger Allee 160 D-23538 Lübeck 1Kinderklinik der Universitât D-55101 Maiaz, Germany 2Lysosornal Diseases Research Unit, Department of Chemical Pathology, Adelaide Children's Hospital North Adetaide, Australia 3Institut für medizinische Genetik der Universität CH-8001 Zünch, Switzerland
*To whom correspondence should be addressed
Received July 7, 1993; Revised August 18, 1993; Accepted August 18, 1993
Mutations of the iduronate-2-sulfatase gene were identified in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Together with another 10 cases reported by us earlier it emerges that about 20% of the patients have deletions of the whole gene or other major structural alterations. One, two or three base pair deletions are found in about 23% of the cases while the remaining about 57% carry point mutations predicting amlno acid replacement, premature termination of translation, or aberrant splicing. Molecular analysis of mRNA in splice site mutants showed that these latter defects frequently resulted in use of cryptic splice sites in exons or introns. 62% of the small deletions and point mutations have occurred in 3 of the 9 iduronate-2-sulfatase gene exons. Knowledge of the primary genetic defect allows fast and reliable carrier detection and prenatal diagnosis as well as insight into the relationship between genotype and phenotype.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Vorechovsky Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., September 15, 2006; (2006) gkl535v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roeser, A. Preusser-Kunze, B. Schmidt, K. Gasow, J. G. Wittmann, T. Dierks, K. von Figura, and M. G. Rudolph A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme PNAS, January 3, 2006; 103(1): 81 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Roca, R. Sachidanandam, and A. R. Krainer Intrinsic differences between authentic and cryptic 5' splice sites Nucleic Acids Res., November 1, 2003; 31(21): 6321 - 6333. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Liu, J. Jelinek, Y. D. Pastore, Y. Guan, J. F. Prchal, and J. T. Prchal Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin Blood, April 15, 2003; 101(8): 3294 - 3301. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, A. B Bellows, and J. N Thompson Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome) J. Med. Genet., January 1, 1999; 36(1): 21 - 27. [Abstract] [Full Text] |
||||
![]() |
N. El-Kassar, G. Hetet, J. Briere, and B. Grandchamp Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets Blood, January 1, 1997; 89(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||



